Data shows just 38 percent of nursing home workers have accepted COVID-19 vaccines

So far, only 38 percent of staffers at nursing homes have accepted COVID-19 vaccines when offered, according to new data released by the Centers for Disease Control and Prevention on Monday.
Due to their vulnerability, nursing home residents and health care workers have been among the first people to receive the vaccine, and "these findings show we have a lot of work to do to increase confidence and also really understand the barriers to vaccination amongst the population," Dr. Radhika Gharpure, lead author of the CDC report, told USA Today.
The report looked at vaccination rates at more than 11,000 long-term care facilities in the U.S. between Dec. 18 and Jan. 17. While the vaccination numbers were low for staffers, 78 percent of residents have received at least one dose of the vaccine. Under a deal reached with CVS and Walgreens during the Trump administration, the pharmacies are sending technicians to participating nursing homes three times in order to vaccinate as many people as possible.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Earlier polling data showed that some nursing home employees said they were concerned about side effects, while others did not want to be among the first group to get vaccinated. Several facilities have been working to educate workers about the vaccine. At Vanderbilt University School of Medicine in Nashville, nearly two-thirds of employees said late last year they did not want to get the vaccine, but infectious disease expert Dr. William Schaffner told USA Today there was a push to share facts with staffers, and that "moved the needle." Now, 75 percent have said they will get the vaccine.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
How Canadian tariffs could impact tourism to the US
In the Spotlight Canadians represent the largest group of foreign visitors to the United States. But they may soon stop visiting.
By Justin Klawans, The Week US Published
-
Entitlements: DOGE goes after Social Security
Feature Elon Musk is pushing false claims about Social Security fraud
By The Week US Published
-
The Week contest: Amazon Bond
Puzzles and Quizzes
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published